Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

English | Polski
Go to the home page of the library Uniwersytet Ekonomiczny we Wrocławiu

Prolib Integro - home pageUniwersytet Ekonomiczny we Wrocławiu

You are browsing as a GUEST

You search for a phrase ""Sévenet, N"" according to the criterion: Author

  Filters

Restrict to:

Align
    Showing 1-5 from 5 results
    Cover preview
    Title :
    Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study.
    Authors :
    Bubien V; INSERM U1218, Mammary & Leukemic Oncogenesis group, Université de Bordeaux, Bordeaux, France.; Cancer Genetics Department, Institut Bergonié, Bordeaux, France.
    Bonnet F; INSERM U1218, Mammary & Leukemic Oncogenesis group, Université de Bordeaux, Bordeaux, France.; Cancer Genetics Department, Institut Bergonié, Bordeaux, France.
    Dupiot-Chiron J; Cancer Genetics Department, Institut Bergonié, Bordeaux, France.
    Barouk-Simonet E; Cancer Genetics Department, Institut Bergonié, Bordeaux, France.
    Jones N; INSERM U1218, Mammary & Leukemic Oncogenesis group, Université de Bordeaux, Bordeaux, France.; Cancer Genetics Department, Institut Bergonié, Bordeaux, France.
    de Reynies A; Programme CIT, Bioinformatics Department, Ligue Nationale contre le Cancer (Cartes d'Identité des Tumeurs), Paris, France.
    MacGrogan G; INSERM U1218, Mammary & Leukemic Oncogenesis group, Université de Bordeaux, Bordeaux, France.; BioPathology Department, Institut Bergonié, Bordeaux, France.
    Sevenet N; INSERM U1218, Mammary & Leukemic Oncogenesis group, Université de Bordeaux, Bordeaux, France.; Cancer Genetics Department, Institut Bergonié, Bordeaux, France.
    Letouzé E; Programme CIT, Bioinformatics Department, Ligue Nationale contre le Cancer (Cartes d'Identité des Tumeurs), Paris, France.
    Longy M; INSERM U1218, Mammary & Leukemic Oncogenesis group, Université de Bordeaux, Bordeaux, France.; Cancer Genetics Department, Institut Bergonié, Bordeaux, France.
    Show more
    Source :
    Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2017 Nov; Vol. 56 (11), pp. 788-799. Date of Electronic Publication: 2017 Aug 16.
    Publication Type :
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms :
    Exome*
    Germ-Line Mutation*
    Ataxia Telangiectasia Mutated Proteins/*genetics
    Breast Neoplasms/*genetics
    Carcinogenesis/*genetics
    Adult ; Aged ; Ataxia Telangiectasia Mutated Proteins/metabolism ; Breast Neoplasms/pathology ; Female ; Gene Expression Profiling ; Gene Frequency ; Humans ; Male ; Middle Aged ; Pedigree ; Polymorphism, Single Nucleotide ; Proof of Concept Study
    Academic Journal
    Details
    Cover preview
    Title :
    BRCA Share: A Collection of Clinical BRCA Gene Variants.
    Authors :
    Béroud C; Aix Marseille Univ, INSERM, GMGF, Marseille, France.; APHM, Hôpital TIMONE Enfants, Laboratoire de Génétique Moléculaire, Marseille, France.
    Letovsky SI; Laboratory Corporation of America, Westborough, Massachusetts.
    Braastad CD; Quest Diagnostics, Marlborough, Massachusetts.
    Caputo SM; Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris, France.
    Beaudoux O; CHU et Institut Jean Godinot, Reims, France.
    Bignon YJ; Centre Jean Perrin, Clermont-Ferrand, France.
    Bressac-De Paillerets B; Institut Gustave Roussy, Villejuif, France.
    Bronner M; CHU de Nancy-Brabois, Vandoeuvre-lés-Nancy, France.
    Buell CM; Quest Diagnostics, Marlborough, Massachusetts.
    Collod-Béroud G; Aix Marseille Univ, INSERM, GMGF, Marseille, France.
    Coulet F; Groupe hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Laboratoire d'Oncogénétique et Angiogénétique moléculaire, Université Pierre et Marie Curie, Paris, France.
    Derive N; Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris, France.
    Divincenzo C; Quest Diagnostics, Marlborough, Massachusetts.
    Elzinga CD; Quest Diagnostics, Marlborough, Massachusetts.
    Garrec C; CHU, Institut de Biologie, Hôtel Dieu, Nantes, France.
    Houdayer C; Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France.
    Karbassi I; Quest Diagnostics, Marlborough, Massachusetts.
    Lizard S; CHU de Dijon, Hôpital d'Enfants, Service de Génétique Médicale, Dijon, France.
    Love A; Quest Diagnostics, Marlborough, Massachusetts.
    Muller D; Centre Paul Strauss, Strasbourg, France.
    Nagan N; Laboratory Corporation of America, Westborough, Massachusetts.
    Nery CR; Quest Diagnostics, San Juan Capistrano, California.
    Rai G; Aix Marseille Univ, INSERM, GMGF, Marseille, France.
    Revillion F; Centre Oscar Lambret, Unité d'Oncologie Moléculaire Humaine, Lille, France.
    Salgado D; Aix Marseille Univ, INSERM, GMGF, Marseille, France.
    Sévenet N; Institut Bergonié, Bordeaux, France.
    Sinilnikova O; Hospices Civils de Lyon and Centre Léon Bérard, Lyon, France.
    Sobol H; Institut Paoli-Calmettes, Marseille, France.
    Stoppa-Lyonnet D; Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France.
    Toulas C; Institut Claudius Régaud, Toulouse, France.
    Trautman E; Laboratory Corporation of America, Westborough, Massachusetts.
    Vaur D; Laboratoire de biologie et de génétique du cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de Médecine Personnalisée, Caen, France.
    Vilquin P; Laboratoire de Biologie Cellulaire et Hormonale (CHU Arnaud de Villeneuve), Montpellier, France.
    Weymouth KS; Laboratory Corporation of America, Westborough, Massachusetts.
    Willis A; Laboratory Corporation of America, Research Triangle Park, North Carolina.
    Eisenberg M; Laboratory Corporation of America, Research Triangle Park, North Carolina.
    Strom CM; Quest Diagnostics, San Juan Capistrano, California.
    Show more
    Corporate Authors :
    Laboratory Corporation of America Variant Classification Group; Laboratory Corporation of America, Westborough, Massachusetts.; Laboratory Corporation of America, Research Triangle Park, North Carolina.
    Quest Diagnostics Variant Classification Group; Quest Diagnostics, Marlborough, Massachusetts.; Quest Diagnostics, San Juan Capistrano, California.
    UNICANCER Genetic Group BRCA Laboratory Network
    Source :
    Human mutation [Hum Mutat] 2016 Dec; Vol. 37 (12), pp. 1318-1328. Date of Electronic Publication: 2016 Sep 28.
    Publication Type :
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms :
    Databases, Factual*/economics
    BRCA1 Protein/*genetics
    BRCA2 Protein/*genetics
    Breast Neoplasms/*genetics
    Ovarian Neoplasms/*genetics
    Data Curation ; Female ; Genetic Predisposition to Disease ; Humans ; Mutation
    Academic Journal
    Details
    Cover preview
    Title :
    Comprehensive analysis of PTEN status in breast carcinomas.
    Authors :
    Jones N; INSERM U916 VINCO, University of Bordeaux, Institut Bergonié, Bordeaux, France.
    Bonnet F
    Sfar S
    Lafitte M
    Lafon D
    Sierankowski G
    Brouste V
    Banneau G
    Tunon de Lara C
    Debled M
    MacGrogan G
    Longy M
    Sevenet N
    Show more
    Source :
    International journal of cancer [Int J Cancer] 2013 Jul 15; Vol. 133 (2), pp. 323-34. Date of Electronic Publication: 2013 Feb 12.
    Publication Type :
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms :
    Gene Expression Regulation, Neoplastic*
    Carcinoma, Ductal, Breast/*genetics
    Carcinoma, Ductal, Breast/*metabolism
    PTEN Phosphohydrolase/*genetics
    Alleles ; Chromosomal Instability ; Chromosomes/ultrastructure ; Class I Phosphatidylinositol 3-Kinases ; DNA Mutational Analysis ; Female ; Humans ; Immunohistochemistry/methods ; In Situ Hybridization, Fluorescence ; Lymph Nodes/pathology ; Phosphatidylinositol 3-Kinases/metabolism ; Point Mutation ; Prognosis ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Tumor Suppressor Protein p53/metabolism
    Academic Journal
    Details
    Cover preview
    Title :
    Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants.
    Authors :
    Houdayer C; Service de Génétique, Institut Curie et Université Paris Descartes, Sorbonne Paris Cité, Paris, France. />Caux-Moncoutier V
    Krieger S
    Barrois M
    Bonnet F
    Bourdon V
    Bronner M
    Buisson M
    Coulet F
    Gaildrat P
    Lefol C
    Léone M
    Mazoyer S
    Muller D
    Remenieras A
    Révillion F
    Rouleau E
    Sokolowska J
    Vert JP
    Lidereau R
    Soubrier F
    Sobol H
    Sevenet N
    Bressac-de Paillerets B
    Hardouin A
    Tosi M
    Sinilnikova OM
    Stoppa-Lyonnet D
    Show more
    Source :
    Human mutation [Hum Mutat] 2012 Aug; Vol. 33 (8), pp. 1228-38. Date of Electronic Publication: 2012 May 11.
    Publication Type :
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms :
    BRCA1 Protein/*genetics
    BRCA2 Protein/*genetics
    Pathology, Molecular/*methods
    Pathology, Molecular/*standards
    RNA Splicing/*genetics
    Exons/genetics ; Female ; Humans
    Academic Journal
    Details
      Showing 1-5 from 5 results

      We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.